Document:

<PAGE>

                                                                    EXHIBIT 4.19

                          REGISTRATION RIGHTS AGREEMENT

      REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of November 24,
2003, by and among REINSURANCE GROUP OF AMERICA, INCORPORATED, a Missouri
corporation (the "Company"), METLIFE, INC., a Delaware corporation ("MetLife"),
METROPOLITAN LIFE INSURANCE COMPANY, a New York life insurance company ("MLIC"),
GENERAL AMERICAN LIFE INSURANCE COMPANY, a Missouri insurance company ("GenAm")
and EQUITY INTERMEDIARY COMPANY, a Missouri corporation ("EIC").

                              W I T N E S S E T H :

      WHEREAS, the Company and MLIC, a wholly owned subsidiary of MetLife, are
parties to the Registration Rights Agreement, dated as of November 23, 1999 (the
"MLIC Registration Rights Agreement"), pursuant to which the Company has granted
to MLIC certain registration and other rights with respect to the Company's
common stock, par value $0.01 per share;

      WHEREAS, the Company and GenAm, a wholly owned subsidiary of MetLife, are
parties to the Registration Rights Agreement, dated as of April 15, 1993 (the
"GenAm Registration Rights Agreement"), pursuant to which the Company has
granted to GenAm certain registration and other rights with respect to the
Company's common stock, par value $0.01 per share;

      WHEREAS, the Company has sold shares of its common stock, par value $0.01
per share, in a public offering (the "2003 Public Offering") and each of MetLife
and EIC has purchased in the 2003 Public Offering 2,205,000 and 795,000 shares
of common stock, respectively;

      WHEREAS, in connection with the purchase of shares of common stock in the
2003 Public Offering by MetLife and EIC, MetLife and the Company have been
negotiating to terminate the MLIC Registration Rights Agreement and the GenAm
Registration Rights Agreement in their entirety and replace them with a new
registration rights agreement as provided herein;

      WHEREAS, the MLIC Registration Rights Agreement provides that it may not
be modified or amended except by an instrument in writing signed by the party
against whom enforcement of any such modification or amendment is sought, and
the GenAm Registration Rights Agreement provides that it may be amended by the
Company and holders of a majority of the Registrable Securities (as defined
thereunder only for purposes of this paragraph and the immediately following
paragraph); and

      WHEREAS, EIC, a wholly-owned subsidiary of GenAm, is the holder of at
least a majority of the Registrable Securities under the GenAm Registration
Rights Agreement, and the Company and MLIC are parties to the MLIC Registration
Rights Agreement.
<PAGE>
      NOW, THEREFORE, in consideration of the mutual covenants and agreements
contained in this Agreement, and for other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, and intending to be
legally bound hereby, the parties hereto hereby agree as follows:

                                    ARTICLE I

                                   DEFINITIONS

      As used in this Agreement, the following terms have the following
respective meanings:

      "Affiliate" shall mean, with respect to any person, any other person who
directly or indirectly controls, is controlled by or is under common control
with such first person. The term "control", for the purposes of this definition,
means the power to direct or cause the direction of the management or policies
of the controlled person, whether through stock ownership, contract or
otherwise.

      "Business Day" shall mean any day other than (i) a Saturday, (ii) a Sunday
or (iii) any other day on which banks are authorized or required to close in New
York, New York.

      "Company" shall have the meaning set forth in the first paragraph hereof.

      "Company Common Stock" shall mean shares of common stock, par value $0.01
per share, of the Company.

      "Confidential Information" shall have the meaning set forth in Section
9.12.

      "Controlling persons" shall have the meaning set forth in Section 7.1.

      "Counterpart" means a counterpart to this Agreement in the form of Exhibit
A, pursuant to the execution of which a person shall become bound by all of the
terms and conditions of this Agreement.

      "Damages" shall have the meaning set forth in Section 7.1.

      "Demand Notice" shall have the meaning set forth in Section 2.1.

      "Demand Registration" shall have the meaning set forth in Section 2.1.

      "Exchange Act" shall mean the Securities Exchange Act of 1934, as amended,
and the rules and regulations thereunder.

      "Filing Date" shall mean the date that is thirty (30) days after the date
of the Demand Notice.

      "GenAm" shall have the meaning set forth in the first paragraph hereof.

      "GenAm Registration Rights Agreement" shall have the meaning set forth in
the third paragraph hereof.

                                       2
<PAGE>
      "MetLife" shall have the meaning set forth in the first paragraph hereof
and, with respect to any Registrable Securities transferred on or after the date
hereof in accordance with Section 9.7, shall also have the meaning set forth in
Section 9.7.

      "MLIC" shall have the meaning set forth in the first paragraph hereof.

      "MLIC Registration Rights Agreement" shall have the meaning set forth in
the second paragraph hereof.

      "NASD" shall mean the National Association of Securities Dealers, Inc.

      "person" shall mean an individual, a partnership, a corporation, a limited
liability company, an association, a joint stock company, a trust, a business
trust, a joint venture, an unincorporated organization or a government entity or
any department, agency or political subdivision thereof.

      "Piggyback Registration" shall have the meaning set forth in Section 3.1.

      "prospectus" means the prospectus included in a registration statement
(including, without limitation, any prospectus subject to completion and a
prospectus that includes any information previously omitted from a prospectus
filed as part of an effective registration statement in reliance upon Rule 430A
promulgated under the Securities Act), as amended or supplemented by any
prospectus supplement, and all other amendments and supplements to such
prospectus, including post-effective amendments, and all material incorporated
by reference or deemed to be incorporated by reference in such prospectus.

      The terms "register, "registered" and "registration" refer to a
registration effected by preparing and filing a registration statement in
compliance with the Securities Act and the declaration or ordering of
effectiveness of such registration statement by the SEC.

      "Registrable Securities" shall mean (i) any shares of Company Common Stock
held by MetLife or any of its Affiliates (other than directors and officers of
MetLife or its Affiliates) at the date hereof or (ii) any shares of Company
Common Stock that MetLife or any of its Affiliates (other than directors and
officers of MetLife or its Affiliates) may acquire after the date hereof or
(iii) any shares of Company Common Stock that any permitted transferee acquires
in connection with such transfer or may acquire after the date of such transfer,
other than, in the case of either clause (i) or (ii), shares held on behalf of
any separate or managed account or by any such Affiliate acting as
broker-dealer, investment advisor, trustee or other fiduciary, it being the
intent that "Registrable Securities" shall only include shares held by MetLife
or such Affiliates for their own account; provided, that a Registrable Security
ceases to be a Registrable Security when (i) it is registered under the
Securities Act and disposed of in accordance with the registration statement
covering it, (ii) it is sold or transferred in accordance with the requirements
of Rule 144 (or similar provisions then in effect) promulgated by the SEC under
the Securities Act ("Rule 144"), or (iii) it is eligible to be sold or
transferred by MetLife or any of its Affiliates or any of their respective
permitted transferees under Rule 144 without being subject to any holding period
or volume limitations thereunder.

      "Registration Expenses" shall have the meaning set forth in Section 6.1.

      "SEC" shall mean the United States Securities and Exchange Commission.

                                       3
<PAGE>
      "Securities Act" shall mean the Securities Act of 1933, as amended, and
the rules and regulations thereunder.

      "Shelf Registration Statement" means a registration statement of the
Company on Form S-3 or any other appropriate form under the Securities Act
including any prospectus included therein, amendments and supplements to such
registration statement, including post-effective amendments, all exhibits, and
all materials incorporated by reference or deemed to be incorporated by
reference in such registration statement, for an offering to be made on a
delayed or continuous basis pursuant to Rule 415 promulgated under the
Securities Act (or similar provisions then in effect) that (i) covers all or any
part of Registrable Securities pursuant to the provisions of this Agreement, and
(ii) sets forth a plan of distribution as determined by MetLife in accordance
with Section 2.2.

      "Subsidiary" shall mean with respect to any person, any other person, of
which such first person, directly or indirectly, owns or controls 50% or more of
the securities or other interests entitled to vote under ordinary circumstances
in the election of directors or others performing similar functions with respect
to such other person, or to otherwise control such other person.

      "Termination Date" shall have the meaning set forth in Section 2.1.

                                   ARTICLE II

                               DEMAND REGISTRATION

      Section 2.1. Request for Shelf Registration. MetLife may make up to six
(6) written requests to the Company (each, a "Demand Notice") that the Company
register the offer and sale of all or any part of the Registrable Securities
under the Securities Act (each, a "Demand Registration"). Upon receipt of the
Demand Notice, the Company shall: (i) prepare and file with the SEC on or prior
to the Filing Date a Shelf Registration Statement, (ii) use its reasonable best
efforts to cause such Shelf Registration Statement to become effective and (iii)
use its reasonable best efforts to keep such Shelf Registration Statement
continuously effective until the earlier of (A) the date when all Registrable
Securities covered by the Shelf Registration Statement have been sold and (B)
the date on which the Registrable Securities covered by the Shelf Registration
Statement are eligible to be sold or transferred under Rule 144 without being
subject to any holding period or volume limitations thereunder (provided that
MetLife has received an opinion of counsel to the Company who is reasonably
acceptable to MetLife covering the matters referred to in this clause (B) and
such opinion is reasonably satisfactory to MetLife), and MetLife and its
Affiliates (other than officers and directors of MetLife and those of its
Affiliates) do not own in excess of 10% of the Company Common Stock (the
"Termination Date").

      Section 2.2. Selection of Plan of Distribution; Underwriters. The offering
of such Registrable Securities pursuant to the Shelf Registration Statement
shall be in the form of either (x) an underwritten offering or (y) through the
use of brokers or in privately negotiated transactions, in either case as
selected by MetLife within no more than five (5) Business Days following the
date of the Demand Notice. In the event that MetLife elects that the offering be
an underwritten offering, MetLife shall also select one or more nationally
recognized firms of investment bankers that is or are reasonably acceptable to
the Company, to act as the lead managing underwriter or underwriters in
connection with such offering and shall select any additional investment bankers
or managers to be used in connection with such offering. The

                                       4
<PAGE>
Company and MetLife shall enter into a customary underwriting agreement with
such underwriter(s) (and MetLife may at its option require that the
representations, warranties and covenants of the Company to or for the benefit
of the underwriter(s) also be made for the benefit of MetLife).

      Section 2.3. Permitted Delay in Filing and Suspensions of Sales.
Notwithstanding the foregoing, if the Company determines in good faith that such
registration, or further sales under an effective Shelf Registration Statement,
will (1) have a material detrimental effect, as reasonably determined in good
faith by the Board of Directors of the Company, on the completion of a
transaction currently being negotiated or a plan currently being considered by
the Board of Directors of the Company that would, if completed, be material to
the Company and its Subsidiaries taken as a whole at the time the right to delay
or withhold efforts or suspend sales is exercised (whether or not a final
decision has been made to undertake such transaction or plan), or (2) involve
initial or continuing disclosure obligations that are not in the best interests
of the Company's stockholders, as reasonably determined in good faith by the
Board of Directors of the Company, then upon advance written notice to MetLife
(a) the Company may delay in filing the Shelf Registration Statement and may
withhold efforts to cause the Shelf Registration Statement to become effective,
but not more than once and for not more than thirty (30) days, or (b) the
Company may request MetLife to, and MetLife shall, suspend any further sales
under the Shelf Registration Statement (or under a registration statement of the
Company which includes Registrable Securities pursuant to Section 3.1), but not
more than twice in any two-year period and for not more than thirty (30) days
each. Notwithstanding anything to the contrary that may be contained in this
Agreement, if the Company exercises its right to delay or to withhold efforts or
suspend sales, the Company shall use its reasonable best efforts to have the
Shelf Registration Statement or such other registration statement filed or
declared effective, or amended (or otherwise bringing the Shelf Registration
Statement or such other registration statement current with appropriate Exchange
Act filings), as the case may be, at the earliest reasonably practicable date
after the Company's reasons for delaying or withholding efforts or suspending
sales are no longer applicable (but subject to the time limitations in the
immediately preceding sentence).

                                  ARTICLE III

                             PIGGYBACK REGISTRATIONS

      Section 3.1. Right to Piggyback. Whenever the Company proposes to register
(including on behalf of a selling stockholder) any shares of Company Common
Stock under the Securities Act (except for the registration of shares of Company
Common Stock to be offered pursuant to an employee benefit plan on Form S-8 or
pursuant to a registration made on Form S-4, or any successor forms or any form
that does not include substantially the same information, other than information
relating to selling shareholders or their plan of distribution, that would be
required to be included in a registration statement covering the sale of the
Registrable Securities) at any time other than pursuant to a Demand
Registration, and the registration form to be used may be used for the
registration of the Registrable Securities (a "Piggyback Registration"), it will
so notify MetLife in writing no later than the earlier to occur of (i) the tenth
(10th) day following the Company's receipt of notice of exercise of other demand
registration rights, or (ii) thirty (30) days prior to the anticipated date of
filing. Subject to the provisions of Section 3.2, the Company will include in
the Piggyback Registration all Registrable Securities with respect to which the
Company has received written requests for inclusion from MetLife within ten (10)
Business Days after MetLife's receipt of the Company's notice. MetLife may
withdraw all or any part of

                                       5
<PAGE>
the Registrable Securities from a Piggyback Registration at any time before five
(5) Business Days prior to the effective date of the Piggyback Registration. The
Company, MetLife and any person who hereafter become entitled to register its
securities in a registration initiated by the Company shall sell their
securities on the same terms and conditions.

      Section 3.2. Priority on Piggyback Registrations. If the managing
underwriter advises the Company in writing (a copy of which shall be provided to
MetLife) that a limitation on the total number of securities to be included in
the Piggyback Registration is advisable in order to avoid a likely material and
adverse effect on the success of the offering, the Company will so advise
MetLife and will include the securities in the registration in the following
order of priority: (i) first, all securities the Company or the holder for whom
the Company is effecting the registration, as the case may be, proposes to sell;
and (ii) second, any other securities requested to be included in the
registration (including Registrable Securities), allocated among the holders of
such securities in proportion (as nearly as practicable) to the number of
securities which each holder requested to be included in the Piggyback
Registration.

      Section 3.3. Underwriters. If any Piggyback Registration is an
underwritten offering, the Company and MetLife shall enter into a customary
underwriting agreement with the underwriter(s) administering the offering.
MetLife may not participate in any Piggyback Registration without (a) agreeing
to sell securities on the basis provided in the underwriting arrangements
approved by the Company, and (b) promptly completing, executing and delivering
all questionnaires, powers of attorney, indemnities, underwriting agreements and
other documents required by the underwriting arrangements.

                                   ARTICLE IV

                          RESTRICTIONS ON PUBLIC SALES

      Section 4.1. Restrictions on Public Sales. The Company shall agree not to
make any public sale or distribution of its common stock, or any securities
convertible into or exchangeable or exercisable for its common stock, including
a sale under Regulation D under the Securities Act or under any other exemption
of the Securities Act (except pursuant to registrations on Forms S-8 or S-4 or
any successor form), during the two (2) days prior to and the 180 days after the
effective date of any underwritten Demand Registration or any underwritten
Piggyback Registration unless the managing underwriter(s) agrees otherwise.

                                   ARTICLE V

                             REGISTRATION PROCEDURES

      Section 5.1. Obligations of the Company. Whenever the Company is required
to effect or cause the registration of the offer and sale of Registrable
Securities pursuant to Article II or Article III, the Company will use its
reasonable best efforts to effect or cause the registration of the offer and
sale of such Registrable Securities in accordance with the intended method(s) of
disposition thereof as quickly as reasonably practicable, and in connection with
any such request the Company shall:

      (a) prepare and file with the SEC a registration statement on the
appropriate form and use its reasonable best efforts to cause the registration
statement to become effective. A

                                       6
<PAGE>
reasonable time before filing a registration statement or prospectus or before
filing any amendments or supplements thereto, the Company will furnish to
MetLife and MetLife's counsel copies of all documents proposed to be filed for
their review, comment and approval, which comment or approval shall be delivered
within a reasonable time after receipt;

      (b) immediately notify MetLife of any stop order threatened or issued by
the SEC and use its reasonable best efforts to prevent the entry of a stop order
or, if entered, to have it rescinded or otherwise removed;

      (c) subject to Section 2.3, prepare and file with the SEC such amendments,
supplements and post-effective amendments to the registration statement and the
corresponding prospectus necessary to keep the registration statement
continuously effective until (x) the Termination Date in the case of a Shelf
Registration Statement or (y) otherwise for 180 days or such shorter period as
may be required to sell all Registrable Securities covered by the registration
statement; and comply with the provisions of the Securities Act with respect to
the disposition of all securities covered by the registration statement during
each period in accordance with MetLife's intended method of disposition as set
forth in the registration statement;

      (d) furnish to MetLife a sufficient number of copies of the registration
statement, each amendment and supplement thereto (in each case including all
exhibits), the corresponding prospectus (including each preliminary prospectus),
and such other documents as MetLife may reasonably request to facilitate the
disposition of Registrable Securities;

      (e) register or qualify the Registrable Securities under securities or
blue sky laws of jurisdictions in the United States as MetLife requests and do
any and all other reasonable acts and things that may be necessary or advisable
to enable MetLife to consummate the disposition of its Registrable Securities in
such jurisdiction, provided that the Company shall not be required to subject
itself to service of process or taxation in such jurisdictions;

      (f) notify MetLife of any event as a result of which the prospectus or any
document incorporated therein by reference contains an untrue statement of a
material fact or omits to state any material fact necessary to make the
statements therein not misleading in light of the circumstances under which such
statements were made, and, subject to Section 2.3, prepare a supplement or
amendment to the prospectus or any such document incorporated therein so that
thereafter the prospectus will not contain an untrue statement of a material
fact or omit to state any material fact necessary to make the statements therein
not misleading in light of the circumstances under which such statements were
made;

      (g) cause all registered Registrable Securities to be listed on each
securities exchange, if any, on which similar securities issued by the Company
are then listed;

      (h) provide an institutional transfer agent and registrar and a CUSIP
number for all Registrable Securities on or before the effective date of the
registration statement;

      (i) enter into such reasonably customary agreements (including an
underwriting agreement in reasonably customary form) and take all other actions
in connection with those agreements as MetLife or the underwriter(s), if any,
reasonably request to expedite or facilitate the disposition of the Registrable
Securities (and MetLife may at its option require that the representations,
warranties and covenants of the Company to or for the benefit of the
underwriter(s) also be made for the benefit of MetLife);

                                       7
<PAGE>
      (j) make reasonably available for inspection by MetLife, any underwriter
participating in any disposition pursuant to the registration statement, and any
attorney, accountant or other agent of MetLife or such underwriter, all
financial and other records, pertinent corporate documents, and properties of
the Company, and cause the Company's officers, directors and employees to supply
all information reasonably requested by MetLife or such underwriter, attorney,
accountant or other agent in connection with the registration statement;
provided that an appropriate confidentiality agreement reasonably satisfactory
to the Company is executed by MetLife and such underwriter, attorney, accountant
or other agent;

      (k) in connection with any underwritten offering, obtain a "cold comfort"
letter from the Company's independent public accountants in customary form and
covering those matters customarily covered by "cold comfort" letters as MetLife
or the managing underwriter reasonably requests, addressed to MetLife, the
Company and the underwriter(s);

      (l) in connection with any underwritten offering, furnish, at the request
of MetLife or any underwriter(s) of the offering, an opinion of counsel
representing the Company for the purposes of the registration, in the form and
substance customarily given to underwriters in an underwritten public offering
and reasonably satisfactory to counsel representing MetLife and the
underwriter(s) of the offering, addressed to MetLife and the underwriter(s);

      (m) comply with all applicable rules and regulations of the SEC, and, if
applicable, make available to its security holders, no later than 90 days after
the end of the 12-month period beginning with the first day of the Company's
first quarter commencing after the effective date of a registration statement,
an earnings statement complying with the provisions of Section 11(a) and Rule
158 of the Securities Act and covering the period of at least twelve (12)
months, but not more than eighteen (18) months, beginning with the first month
after the effective date of the registration statement;

      (n) cooperate with MetLife and each underwriter participating in the
disposition of such Registrable Securities and their respective counsel in
connection with any filings required to be made with the NASD;

      (o) in connection with any underwritten offering, participate, to the
extent reasonably requested by MetLife or the managing underwriter or
underwriters for the offering, in customary efforts to sell the securities under
the offering, including, without limitation, participating in "road shows,"
unless the Company demonstrates to MetLife's reasonable satisfaction that such
participation will materially interfere with the management of the Company's
business; and

      (p) take all other steps reasonably necessary to effect the registration
of the Registrable Securities contemplated hereby.

      Section 5.2. MetLife Information. In the event of any registration by the
Company, the Company may request from time to time that MetLife furnish to the
Company information regarding MetLife and its affiliates and associates and the
distribution of the securities subject to the registration, and MetLife shall
furnish all such information reasonably requested by the Company.

      Section 5.3. Notice by MetLife. Whenever MetLife has requested that any
Registrable Securities be registered pursuant to this Agreement, MetLife shall
notify the Company, at any time when a prospectus relating thereto is required
to be delivered under the Securities Act, of

                                       8
<PAGE>
the happening of any event which to its knowledge relates to matters concerning
MetLife or its Affiliates or associates, as a result of which the prospectus
included in the registration statement contains an untrue statement of a
material fact or omits to state any material fact necessary to make the
statements therein, in light of the circumstances under which they were made,
not misleading.

      Section 5.4. "Market Stand-Off" Agreement. MetLife, if reasonably
requested in writing by the managing underwriter(s) of an underwritten public
offering by the Company of the Company's common stock, or securities convertible
into or exchangeable or exercisable for its common stock, agrees not to sell,
make any short sale of, loan, grant any option for the purchase of, or otherwise
transfer or dispose of, directly or indirectly, any Registrable Securities owned
by MetLife (other than (x) any transaction on behalf of any separate or managed
account or any transaction by MetLife or any subsidiary of MetLife acting as
broker-dealer, investment advisor, trustee or other fiduciary in the ordinary
course of its business (collectively, a "Fiduciary Affiliate"), (y) to a
Subsidiary or Affiliate of MetLife, or (z) Registrable Securities included in
such public offering) without the prior written consent of such managing
underwriter(s) during a period of up to two (2) days prior to and 180 days
following the effective date of such underwritten registration of the Company's
securities, but only to the extent that Registrable Securities owned by MetLife
have not been requested to be included in such underwritten registration
following the Company's compliance with Article III. Such agreement shall be in
writing in form reasonably satisfactory to such managing underwriter(s), and may
be included in the underwriting agreement. The Company may impose stop-transfer
instructions with respect to the securities subject to the foregoing restriction
until the end of the required stand-off period and shall lift such stop-transfer
restrictions immediately upon the end of such period.

                                   ARTICLE VI

                             REGISTRATION EXPENSES

      Section 6.1. Generally. All Registration Expenses incident to the
Company's performance of or compliance with this Agreement shall be paid by the
Company. The term "Registration Expenses" includes, without limitation, all
registration filing fees, professional fees and other expenses of the Company's
compliance with federal and state securities laws (including fees and
disbursements of counsel for the underwriter(s) in connection with state
securities law qualifications and registrations), printing expenses, messenger,
telephone and delivery expenses; fees and disbursements of counsel for the
Company and reasonable fees and disbursements of one counsel for MetLife; fees
and disbursements of all independent certified public accountants (including the
expenses relating to any audit or "cold comfort" letters required by or incident
to the performance of the obligations contemplated by this Agreement); fees and
expenses of the underwriter(s) (excluding discounts and commissions) customarily
borne by the issuer in transactions of that kind; fees and expenses of any
special experts retained by the Company at the reasonable request of the
managing underwriter(s) in connection with the registration and as shall be
customary in transactions of that kind; and applicable stock exchange and NASD
registration and filing fees. The term "Registration Expenses" does not include
MetLife's internal expenses (including, without limitation, all salaries and
expenses of its officers and employees performing legal or accounting duties),
any fees or disbursements of any other counsel for MetLife, or the underwriting
discounts or commissions or transfer taxes applicable to the Registrable
Securities, all of which shall be paid by MetLife.

                                        9
<PAGE>
                                  ARTICLE VII

                                 INDEMNIFICATION

      Section 7.1. Indemnification by the Company. In the event of any
registration of Registrable Securities under the Securities Act pursuant to this
Agreement, to the fullest extent permitted by law, the Company agrees to
indemnify MetLife, its officers, directors, trustees, partners, employees,
advisors and agents, and each person who controls MetLife (within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act), together
with all officers, directors, trustees, partners, employees, advisors and agents
of such controlling person (collectively, "Controlling persons"), against all
losses, claims, damages, liabilities, attorneys' fees, costs and expenses and
expenses of investigating and defending any claims (collectively, "Damages")
that arise out of, or are based upon, any untrue or allegedly untrue statement
of a material fact contained in any registration statement under which such
Registrable Securities were registered under the Securities Act or any
prospectus or preliminary prospectus contained therein or any omission or
alleged omission to state a material fact required to be stated therein or
necessary to make the statements contained therein not misleading in light of
the circumstances under which such statements were made, except to the extent
the untrue statement or omission resulted from information that MetLife
furnished in writing to the Company expressly for use therein and except to the
extent that the Company advised MetLife not to dispose of any Registrable
Securities pursuant to Section 2.3 hereof and MetLife disregarded such advice.
In connection with a firm or best efforts underwritten offering, to the extent
customarily required by the managing underwriter, the Company will indemnify the
underwriters, their officers, directors, trustees, partners, employees, advisors
and agents, and each person who controls the underwriters (within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act), and each of
the Underwriter's Controlling persons, to the extent customary in such
agreements.

      Section 7.2. Indemnification by MetLife. In the event of any registration
of Registrable Securities under the Securities Act pursuant to this Agreement,
to the fullest extent permitted by law, MetLife agrees to indemnify the Company,
its officers, directors, trustees, partners, employees, advisors and agents, and
each person who controls the Company (within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act), and each of the Company's
Controlling persons, against any Damages that arise out of, or are based upon
any untrue or allegedly untrue statement of a material fact contained in any
registration statement under which such Registrable Securities were registered
under the Securities Act or any prospectus or preliminary prospectus contained
therein or any omission or alleged omission to state a material fact required to
be stated therein or necessary to make the statements contained therein not
misleading in light of the circumstances under which such statements were made,
but only to the extent that the untrue statement or omission is contained in or
omitted from any information MetLife furnished in writing to the Company
expressly for use therein and only in an amount not exceeding the net proceeds
received by MetLife with respect to securities sold pursuant to such
registration statement and except to the extent that the Company advised MetLife
not to dispose of any Registrable Securities pursuant to Section 2.3 hereof and
MetLife disregarded such advice. In connection with a firm or best efforts
underwritten offering, to the extent customarily required by the managing
underwriter, MetLife will indemnify the underwriters, their officers, directors,
trustees, partners, employees, advisors and agents, and each person who controls
the underwriters (within the meaning of Section 15 of the Securities

                                       10
<PAGE>
Act or Section 20 of the Exchange Act), and each of the underwriters'
Controlling persons, to the extent customary in such agreements.

      Section 7.3. Indemnification Proceedings. Any person entitled to
indemnification under this Agreement will (i) give prompt (but in no event more
than thirty (30) days') notice to the indemnifying party of any claim with
respect to which it seeks indemnification (provided, however, that failure to so
promptly notify the indemnifying party shall not relieve the indemnifying party
from liability except to the extent the indemnifying party is prejudiced
thereby) and (ii) unless in the indemnified party's reasonable judgment a
conflict of interest may exist between the indemnified and indemnifying parties
with respect to the claim, permit the indemnifying party, at its expense, to
assume the defense of the claim with counsel reasonably satisfactory to the
indemnified party. If the indemnifying party does not assume the defense, the
indemnifying party will not be liable for any compromise or settlement made
without its consent or judgment consented to without its consent, but any such
consent shall not be unreasonably withheld. An indemnifying party who is not
entitled to or elects not to assume the defense of a claim will not be under an
obligation to pay the reasonable fees and expenses of more than one counsel for
all parties indemnified by the indemnifying party with respect to the claim,
unless in the reasonable judgment of any indemnified party a conflict of
interest may exist between the indemnified party and any other indemnified party
with respect to the claim, in which event the indemnifying party shall be
obligated to pay the reasonable fees and expenses of no more than one additional
counsel for the indemnified parties. Notwithstanding anything to the contrary
that may be contained in this Section 7.3, the indemnifying party shall not,
without the indemnified party's prior written consent, which consent shall not
be unreasonably withheld, settle or compromise any claim or consent to the entry
of any judgment in respect thereof which imposes any future obligation on the
indemnified party or which does not include, as an unconditional term thereof,
the giving by the claimant or plaintiff to the indemnified party, a release from
all liability in respect of such claim.

      Section 7.4. Contribution. If the indemnification provided for in Sections
7.1 or 7.2 is unavailable to an indemnified party in respect of any Damages
referred to therein, then each indemnifying party thereunder shall contribute to
the amount paid or payable by such indemnified party as a result of such Damages
in such proportion as is appropriate to reflect the relative fault of and
relative benefit to the Company and MetLife in connection with the statements or
omissions that resulted in such Damages, as well as any other relevant equitable
considerations. The relative fault of the Company and MetLife shall be
determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company or by MetLife and
the parties' relative intent and knowledge. The parties hereto agree that it
would not be just and equitable if contribution pursuant to this Section 7.4
were determined by pro rata allocation or by any other method of allocation that
does not take account of the equitable considerations referred to in the
immediately preceding sentence. Notwithstanding anything herein to the contrary,
MetLife shall not be required to contribute any amount in excess of the amount
by which the net proceeds of the offering (before deducting expenses, if any)
received by MetLife exceeds the amount of any Damages that MetLife has otherwise
been required to pay by reason of such untrue or alleged untrue statement or
omission or alleged omission. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation.

                                       11
<PAGE>
                                  ARTICLE VIII

                     SECURITIES ACT AND EXCHANGE ACT FILINGS

      Section 8.1. Securities Act and Exchange Act Filings. The Company
covenants that it will promptly file all documents required to be filed by it
under the Securities Act and the Exchange Act and the rules and regulations
promulgated by the SEC thereunder, including, without limitation, pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, and it will take such
further action as MetLife reasonably may request, all to the extent required
from time to time, so that the Company will qualify for registration on Form S-3
and to enable MetLife to sell Registrable Securities without registration under
the Securities Act within the limitation of the exemptions provided by (i) Rule
144 under the Securities Act, or (ii) any similar rule or regulation hereafter
promulgated by the SEC. Upon the request of MetLife, the Company will deliver to
MetLife a written statement as to whether it has complied with Rule 144's or any
successor rule's requirements.

                                   ARTICLE IX

                                  MISCELLANEOUS

      Section 9.1. Recapitalizations, Exchanges, etc. Notwithstanding anything
to the contrary that may be contained in this Agreement, the provisions of this
Agreement shall apply to the full extent set forth herein with respect to (i)
any shares of Company Common Stock, now or hereafter authorized to be issued,
(ii) any and all shares of voting common stock of the Company into which the
shares of Company Common Stock are converted, exchanged or substituted in any
recapitalization or other capital reorganization by the Company and (iii) any
and all securities of any kind whatsoever of the Company or any successor or
assign of the Company (whether by merger, consolidation, sale of assets or
otherwise) which may be issued on or after the date hereof in respect of, in
conversion of, in exchange for or in substitution of, the shares of Company
Common Stock, and shall be appropriately adjusted for any stock dividends, or
other distributions, stock splits or reverse stock splits, combinations,
recapitalizations mergers, consolidations, exchange offers or other
reorganizations occurring after the date hereof.

      Section 9.2. Counterparts. This Agreement may be executed in one or more
counterparts, all of which shall be considered one and the same agreement, and
shall become effective when one or more counterparts have been signed by each
party hereto and delivered to the other party. Copies of executed counterparts
transmitted by telecopy, telefax or other electronic transmission service shall
be considered original executed counterparts for purposes of this Section,
provided receipt of copies of such counterparts is confirmed.

      Section 9.3. Governing Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of Missouri without reference
to the choice of law principles thereof, except for the validity of corporate
action by the parties hereto, which shall be governed by and construed in
accordance with the laws of the jurisdiction of incorporation or organization of
such party.

      Section 9.4. Entire Agreement. This Agreement, and the certificates,
instruments and other documents delivered pursuant hereto, contain the entire
agreement between the parties hereto with respect to the subject matter hereof
and there are no agreements, understandings,

                                       12
<PAGE>
representations or warranties between the parties hereto other than those set
forth or referred to herein. This Agreement is not intended to confer upon any
person not a party hereto any rights or remedies hereunder.

      Section 9.5. Notices. All notices and other communications hereunder shall
be sufficiently given for all purposes hereunder if in writing and delivered
personally, sent by documented overnight delivery service or, to the extent
receipt is confirmed, telecopy, telefax or other electronic transmission service
to the appropriate address or number as set forth below. If sent via overnight
delivery service, notice is deemed to have been received on the next succeeding
Business Day.

                  Notices to the Company shall be addressed to:

                  Reinsurance Group of America, Incorporated
                  1370 Timberlake Manor Parkway
                  Chesterfield, Missouri 63107-6039
                  Attention: Jack B. Lay, Executive Vice President and Chief
                  Financial Officer
                  Telecopy: 636-736-7839

                  with copies to:

                  Reinsurance Group of America, Incorporated
                  1370 Timberlake Manor Parkway
                  Chesterfield, Missouri 63017
                  Attention: James E. Sherman, Esq.
                  Telecopy: 636-736-7886

                  Bryan Cave LLP
                  One Metropolitan Square
                  211 North Broadway
                  St. Louis, Missouri 63102-2750
                  Attention: R. Randall Wang, Esq.
                  Telecopy: 314-259-2020

                  Notices to MetLife shall be addressed to:

                  MetLife, Inc.
                  One Madison Avenue
                  New York, New York 10010
                  Attention: James L. Lipscomb
                  Telecopy: 212-252-7288

                                       13
<PAGE>
                  with a copy to:

                  Debevoise & Plimpton
                  919 Third Avenue
                  New York, New York 10022
                  Attention: Alan H. Paley, Esq.
                  Telecopy: 212-909-6836

Either party may change the person, address and number to which notices are to
be sent by giving written notice of any such change in the manner provided
herein.

      Section 9.6. Successors and Assigns. This Agreement shall be binding upon
and inure to the benefit of the parties hereto and their respective successors
and permitted assigns. This Agreement may not be assigned by either party hereto
without the prior written consent of the other party, except that MetLife may
assign its rights hereunder to a Subsidiary or Affiliate of MetLife (and such
Subsidiary or Affiliate shall execute a Counterpart and deliver same to the
Company prior to or at the time of assignment) or in accordance with Section 9.7
without the consent of the Company.

      Section 9.7. Transfer of Registration Rights. Provided that the Company is
given written notice by MetLife prior to or at the time of such transfer stating
the name and address of the transferee and identifying the securities with
respect to which the rights under this Agreement are being assigned, the
registration rights under this Agreement may be transferred with the transfer of
Registrable Securities. Notwithstanding the foregoing, if such transfer is
subject to covenants, agreements or other undertakings restricting
transferability thereof, the registration rights under this Agreement shall not
be transferred in connection with such transfer unless such transfer complies
with all such covenants, agreements and other undertakings. In all cases, such
registration rights shall not be transferred unless the transferee thereof
executes a Counterpart and delivers same to the Company. Upon a transfer in
compliance with this Section 9.7, all references in this Agreement to "MetLife"
shall be deemed to refer in addition to any transferee hereunder with respect to
such transferred Registrable Securities. Notwithstanding anything to the
contrary that may be contained in this Agreement, in the event that MetLife does
not transfer all of the Registrable Securities or transfers the Registrable
Securities to more than one transferee, the holders of the Registrable
Securities thereafter shall be entitled to take any action hereunder by majority
vote of all Registrable Securities or by majority vote of the Registrable
Securities which are the subject of such registration, as appropriate.

      Section 9.8. Headings. The headings contained in this Agreement are
inserted for convenience of reference only and will not affect the meaning or
interpretation of this Agreement. All references in this Agreement to Sections,
Articles or Exhibits mean Sections or Articles of or Exhibits to this Agreement
unless otherwise stated.

      Section 9.9. Amendments and Waivers. This Agreement may not be modified or
amended except by an instrument or instruments in writing signed by the party
against whom enforcement of any such modification or amendment is sought. Either
party hereto may waive compliance by the other party hereto with any term or
provision hereof on the part of such other party hereto to be performed or
complied with only by an instrument in writing. The waiver by any party hereto
of a breach of any term or provision hereof shall not be construed as a waiver
of any subsequent breach.

                                       14
<PAGE>
      Section 9.10. Severability. Any provision hereof which is invalid or
unenforceable shall be ineffective to the extent of such invalidity or
unenforceability, without affecting in any way the remaining provisions hereof.

      Section 9.11. No Inconsistent Agreements. The Company represents and
warrants that it has not granted to any person the right to request or require
the Company to register any securities issued by the Company other than pursuant
to this Agreement, the MLIC Registration Rights Agreement and the GenAm
Registration Rights Agreement. Except with the prior written consent of MetLife,
the Company will not enter into any agreement with respect to its securities
that shall grant to any person registration rights that in any way conflict with
or are prior in right to the rights provided under this Agreement.

      Section 9.12. Confidentiality. Notwithstanding anything to the contrary in
this Agreement, MetLife may not use any Confidential Information received by it
from the Company pursuant to this Agreement in violation of the Exchange Act or
reproduce, disclose or disseminate such information to any person (other than
its directors, officers, employees, financial advisors, legal advisors,
accountants, consultants and other persons having a reasonable reason for
knowing the contents of such information and who agree for the benefit of the
Company (in writing, with respect to financial advisors, legal advisors,
accountants and consultants) to be bound hereby), unless such information is (i)
available to the public generally (other than by the recipient in violation of
any confidentiality agreement or obligation with the Company), (ii) available to
MetLife or such recipient on a non-confidential basis from a third party that is
not, to MetLife's or such recipient's knowledge, bound by any other
confidentiality agreement or obligation with the Company or (iii) required to be
disclosed by MetLife or such recipient by a governmental body or regulatory
agency or by law. "Confidential Information" shall mean only the following
information: (i) confidential or proprietary information of the Company supplied
by or on behalf of the Company which MetLife requested in writing to the Company
pursuant to this Agreement and (ii) the fact that the Company requested that
MetLife suspend further sales pursuant to Section 2.3. Notwithstanding anything
to the contrary in this Agreement, MetLife and the Company agree that the
Company shall not furnish to MetLife any of its confidential or proprietary
information, including without limitation, in advance of the filing of any
registration statement (including the Shelf Registration Statement) or
prospectus or any amendment or supplement thereof, except upon receipt of a
written request from MetLife.

      Section 9.13. Effectiveness; Termination. The Company, MetLife, MLIC ,
GenAm and EIC agree that upon execution of this Agreement, the MLIC Registration
Rights Agreement and the GenAm Registration Rights Agreement will be terminated
in their entirety and of no further force and effect. This Agreement shall
expire, and the rights and obligations of the parties shall terminate, at such
time as MetLife (together with its Affiliates, other than Fiduciary Affiliates)
no longer beneficially owns in excess of 5% of the outstanding Company Common
Stock.

                                       15
<PAGE>
      IN WITNESS WHEREOF, this Agreement has been duly executed by or on behalf
of each of the parties hereto as of the date first above written.

                             REINSURANCE GROUP OF AMERICA, INCORPORATED

                             By: /s/ Jack B. Lay
                                 -----------------
                                 Name:  Jack B. Lay
                                 Title: Executive Vice President and Chief
                                 Financial Officer

                             METLIFE, INC.

                             By: /s/ Anthony J. Williamson
                                 -------------------------
                                 Name:  Anthony J. Williamson
                                 Title: SVP & Treasurer

                             METROPOLITAN LIFE INSURANCE COMPANY

                             By: /s/ Anthony J. Williamson
                                 -------------------------
                                 Name:  Anthony J. Williamson
                                 Title: SVP & Treasurer

                             GENERAL AMERICAN LIFE INSURANCE COMPANY

                             By: /s/ Anthony J. Williamson
                                 -------------------------
                                 Name:  Anthony J. Williamson
                                 Title: Vice President & Treasurer

                             EQUITY INTERMEDIARY COMPANY

                             By: /s/ Anthony J. Williamson
                                 -------------------------
                                 Name:  Anthony J. Williamson
                                 Title: Director, Vice President & Treasurer

                                       16
<PAGE>
                   EXHIBIT A TO REGISTRATION RIGHTS AGREEMENT

                                   COUNTERPART

      THIS INSTRUMENT forms part of the Registration Rights Agreement (the
"Agreement"), dated as of November [ ], 2003, by and among REINSURANCE GROUP OF
AMERICA, INCORPORATED, a Missouri corporation (the "Company"), METLIFE, INC., a
Delaware corporation, METROPOLITAN LIFE INSURANCE COMPANY, a New York life
insurance company, GENERAL AMERICAN LIFE INSURANCE COMPANY, a Missouri life
insurance company, and EQUITY INTERMEDIARY COMPANY, a Missouri corporation,
which Agreement permits execution (including by facsimile) by counterpart. The
undersigned hereby acknowledges having received a copy of the Agreement (which
is annexed hereto as Schedule I) and having read the Agreement in its entirety,
and for good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, and intending to be legally bound, hereby agrees that the
terms and conditions of the Agreement binding upon and inuring to the benefit of
MetLife shall be binding upon and inure to the benefit of the undersigned and
its successors and permitted assigns as if it were the original MetLife
thereunder.

      IN WITNESS WHEREOF, the undersigned has executed this instrument this ___
day of ____________, ___.

                                         ___________________________________
                                         (Signature of Transferee)

                                         ___________________________________
                                         (Name in Block Letters)<PAGE>

                                                                   EXHIBIT 10.12

                   REINSURANCE GROUP OF AMERICA, INCORPORATED

                               FLEXIBLE STOCK PLAN

                 AS AMENDED AND RESTATED EFFECTIVE JULY 1, 1998
<PAGE>
                   REINSURANCE GROUP OF AMERICA, INCORPORATED
                               FLEXIBLE STOCK PLAN

                                TABLE OF CONTENTS

                                                                            Page
                                                                            ----

ARTICLE I - NAME AND PURPOSE
        1.1    Name                                                           1
        1.2    Purpose                                                        1

ARTICLE II - DEFINITIONS OF TERMS AND RULES OF CONSTRUCTION
        2.1    General Definitions                                            1
               (a)    Affiliate                                               1
               (b)    Agreement                                               1
               (c)    Benefit                                                 1
               (d)    Board                                                   1
               (e)    Cash Award                                              1
               (f)    Change of Control                                       1
               (g)    Code                                                    1
               (h)    Company                                                 1
               (i)    Committee                                               1
               (j)    Common Stock                                            2
               (k)    Effective Date                                          2
               (l)    Employee                                                2
               (m)    Employer                                                2
               (n)    Exchange Act                                            2
               (o)    Fair Market Value                                       2
               (p)    Fiscal Year                                             2
               (q)    ISO                                                     2
               (r)    NQSO                                                    2
               (s)    Option                                                  2
               (t)    Other Stock Based Award                                 2
               (u)    Parent                                                  2
               (v)    Participant                                             2
               (w)    Performance Share                                       2
               (x)    Plan                                                    2
               (y)    Restricted Stock                                        3
               (z)    Rule 16b-3                                              3
               (aa)   SEC                                                     3
               (bb)   Share                                                   3
               (cc)   SAR                                                     3
               (dd)   Subsidiary                                              3
        2.2    Other Definitions                                              3
        2.3    Conflicts in Plan                                              3

ARTICLE III - COMMON STOCK
        3.1    Number of Shares                                               3
        3.2    Reusage                                                        3
        3.3    Adjustments                                                    3

ARTICLE IV - ELIGIBILITY
        4.1    Determined By Committee                                         4

                                       ii
<PAGE>
ARTICLE V - ADMINISTRATION
        5.1    Committee                                                      4
        5.2    Authority                                                      4
        5.3    Delegation                                                     5
        5.4    Adjudication of Claims                                         5

ARTICLE VI - AMENDMENT
        6.1    Power of Board                                                 5
        6.2    Limitation                                                     5

ARTICLE VII - TERM AND TERMINATION
        7.1    Term                                                           6
        7.2    Termination                                                    6

ARTICLE VIII - MODIFICATION OR TERMINATION OF BENEFITS
        8.1    General                                                        6
        8.2    Committee's Right                                              6

ARTICLE IX - CHANGE OF CONTROL
        9.1    Right of Committee                                             6

ARTICLE X - AGREEMENTS AND CERTAIN BENEFITS
        10.1   Grant Evidenced by Agreement                                   7
        10.2   Provisions of Agreement                                        7
        10.3   Certain Benefits                                               7

ARTICLE XI - REPLACEMENT AND TANDEM AWARDS
        11.1   Replacement                                                    7
        11.2   Tandem Awards                                                  7

ARTICLE XII - PAYMENT, DIVIDENDS, DEFERRAL AND WITHHOLDING
        12.1   Payment                                                        7
        12.2   Dividend Equivalents                                           8
        12.3   Deferral                                                       8
        12.4   Withholding                                                    8

ARTICLE XIII - OPTIONS
        13.1   Types of Options                                               8
        13.2   Shares for ISOs                                                8
        13.3   Grant of ISOs and Option Price                                 8
        13.4   Other Requirements for ISOs                                    8
        13.5   NQSOs                                                          8
        13.6   Determination by Committee                                     8
        13.7   Limitation Shares Covered by Options                           9

ARTICLE XIV - SARS
        14.1   Grant and Payment                                              9
        14.2   Grant of Tandem Award                                          9
        14.3   ISO Tandem Award                                               9
        14.4   Payment of Award                                               9
        14.5   Limitation on SARs.                                            9

                                      iii
<PAGE>
ARTICLE XV - RESTRICTED STOCK
        15.1   Description                                                    9
        15.2   Cost of Restricted Stock                                       9
        15.3   Non-Transferability                                           10

ARTICLE XVI - PERFORMANCE SHARES
        16.1   Description                                                   10
        16.2   Grant                                                         10

ARTICLE XVII - CASH AWARDS
        17.1   Grant                                                         10
        17.2   Limitation on Amount                                          10
        17.3   Restrictions                                                  10

ARTICLE XVIII - OTHER STOCK BASED AWARDS AND OTHER BENEFITS
        18.1   Other Stock Based Awards                                      10
        18.2   Other Benefits                                                10

ARTICLE XIX - MISCELLANEOUS PROVISIONS
        19.1   Underscored References                                        10
        19.2   Number and Gender                                             11
        19.3   Governing Law                                                 11
        19.4   Purchase for Investment                                       11
        19.5   No Employment Contract                                        11
        19.6   No Effect on Other Benefits                                   11

                                       iv
<PAGE>
                   REINSURANCE GROUP OF AMERICA, INCORPORATED
                               FLEXIBLE STOCK PLAN

                                    ARTICLE I

                                NAME AND PURPOSE

            1.1 Name. The name of this Plan is the "Reinsurance Group of
America, Incorporated Flexible Stock Plan."

            1.2 Purpose. The Company has established this Plan to attract,
retain, motivate and reward Employees and other individuals, to encourage
ownership of the Company's Common Stock by Employees and other individuals, and
to promote and further the best interests of the Company by granting cash and
other awards.

                                   ARTICLE II

                 DEFINITIONS OF TERMS AND RULES OF CONSTRUCTION

            2.1 General Definitions. The following words and phrases, when used
in the Plan, unless otherwise specifically defined or unless the context clearly
otherwise requires, shall have the following respective meanings:

            (a) Affiliate. A Parent or Subsidiary of the Company.

            (b) Agreement. The document which evidences the grant of any Benefit
under the Plan and which sets forth the Benefit and the terms, conditions and
provisions of, and restrictions relating to, such Benefit.

            (c) Benefit. Any benefit granted to a Participant under the Plan.

            (d) Board. The Board of Directors of the Company.

            (e) Cash Award. A Benefit payable in the form of cash.

            (f) Change of Control. The acquisition, without the approval of the
Board, by any person or entity, other than the Company or a Related Entity, of
more than 20% of the outstanding Shares through a tender offer, exchange offer
or otherwise; the liquidation or dissolution of the Company following a sale or
other disposition of all or substantially all of its assets; a merger or
consolidation involving the Company which results in the Company not being the
surviving parent corporation; or any time during any two-year period in which
individuals who constituted the Board at the start of such period (or whose
election was approved by at least two-thirds of the then members of the Board
who were members at the start of the two-year period) do not constitute at least
50% of the Board for any reason. A Related Entity is the Parent, a Subsidiary or
any employee benefit plan (including a trust forming a part of such a plan)
maintained by the Parent, the Company or a Subsidiary.

            (g) Code. The Internal Revenue Code of 1986, as amended. Any
reference to the Code includes the regulations promulgated pursuant to the Code.

            (h) Company. Reinsurance Group of America, Incorporated.

            (i) Committee. The Committee described in Section 5.1.

                                       1
<PAGE>
            (j) Common Stock. Any class of the Company's common stock.

            (k) Effective Date. The date that the Plan is approved by the
shareholders of the Company which must occur within one year before or after
approval by the Board. Any grants of Benefits prior to the approval by the
shareholders of the Company shall be void if such approval is not obtained.

            (l) Employee. Any person employed by the Employer.

            (m) Employer. The Company and all Affiliates.

            (n) Exchange Act. The Securities Exchange Act of 1934, as amended.

            (o) Fair Market Value. The closing price of Shares on the New York
Stock Exchange on a given date, or, in the absence of sales on a given date, the
closing price on the New York Stock Exchange on the last day on which a sale
occurred prior to such date.

            (p) Fiscal Year. The taxable year of the Company which is the
calendar year.

            (q) ISO. An Incentive Stock Option as defined in Section 422 of the
Code.

            (r) NQSO. A Non-Qualified Stock Option, which is an Option that does
not qualify as an ISO.

            (s) Option. An option to purchase Shares granted under the Plan.

            (t) Other Stock Based Award. An award under ARTICLE XVIII that is
valued in whole or in part by reference to, or is otherwise based on, Common
Stock.

            (u) Parent. Any corporation (other than the Company or a Subsidiary)
in an unbroken chain of corporations ending with the Company, if, at the time of
the grant of an Option or other Benefit, each of the corporations (other than
the Company or a Subsidiary) owns stock possessing 50% or more of the total
combined voting power of all classes of stock in one of the other corporations
in such chain. The Company's present Parent is General American Life Insurance
Company.

            (v) Participant. An individual who is granted a Benefit under the
Plan. Benefits may be granted only to Employees, employees and owners of
entities which are not Affiliates but which have a direct or indirect ownership
interest in an Employer or in which an Employer has a direct or indirect
ownership interest, individuals who, and employees and owners of entities which,
are customers and suppliers of an Employer, individuals who, and employees and
owners of entities which, render services to an Employer, and individuals who,
and employees and owners of entities which, have ownership or business
affiliations with any individual or entity previously described.

            (w) Performance Share. A Share awarded to a Participant under
ARTICLE XVI of the Plan.

            (x) Plan. The Reinsurance Group of America, Incorporated Flexible
Stock Plan and all amendments and supplements to it.

                                       2
<PAGE>
            (y) Restricted Stock. Shares issued under ARTICLE XV of the Plan.

            (z) Rule 16b-3. Rule 16b-3 promulgated by the SEC under the Exchange
Act, as amended, or any successor rule in effect from time to time.

            (aa) SEC. The Securities and Exchange Commission.

            (bb) Share. A share of Common Stock.

            (cc) SAR. A Stock Appreciation Right, which is the right to receive
an amount equal to the appreciation, if any, in the Fair Market Value of a Share
from the date of the grant of the right to the date of its payment.

            (dd) Subsidiary. Any corporation, other than the Company, in an
unbroken chain of corporations beginning with the Company if, at the time of
grant of an Option or other Benefit, each of the corporations, other than the
last corporation in the unbroken chain, owns stock possessing 50% or more of the
total combined voting power of all classes of stock in one of the other
corporations in such chain.

            2.2 Other Definitions. In addition to the above definitions, certain
words and phrases used in the Plan and any Agreement may be defined in other
portions of the Plan or in such Agreement.

            2.3 Conflicts in Plan. In the case of any conflict in the terms of
the Plan relating to a Benefit, the provisions in the ARTICLE of the Plan which
specifically grants such Benefit shall control those in a different ARTICLE.

                                   ARTICLE III

                                  COMMON STOCK

            3.1 Number of Shares. The number of Shares which may be issued or
sold or for which Options, SARs or Performance Shares may be granted under the
Plan shall initially be 825,000 Shares. Such number of Shares shall increase
annually, effective as of the first day of each Fiscal Year, commencing with the
Fiscal Year beginning in 1994, by the number of Shares equal to 5% of the number
of Shares allocated to this Plan as of the first day of such Fiscal Year. Such
Shares may be authorized but unissued Shares, Shares held in the treasury, or
both.

            3.2 Reusage. If an Option or SAR expires or is terminated,
surrendered, or cancelled without having been fully exercised, if Restricted
Shares or Performance Shares are forfeited, or if any other grant results in any
Shares not being issued, the Shares covered by such Option or SAR, grant of
Restricted Shares, Performance Shares or other grant, as the case may be, shall
again be available for use under the Plan.

            3.3 Adjustments. If there is any change in the Common Stock of the
Company by reason of any stock dividend, spin-off, split-up, spin-out,
recapitalization, merger, consolidation, reorganization, combination or exchange
of shares, the number of SARs and number and class of shares available for
Options and grants of Restricted Stock, Performance Shares and Other Stock Based
Awards and the number of Shares subject to outstanding Options, SARs, grants of
Restricted Stock and Performance Shares which are not vested, and Other Stock
Based Awards, and the price thereof, as applicable, shall be appropriately
adjusted by the Committee.

                                       3
<PAGE>
                                   ARTICLE IV

                                   ELIGIBILITY

            4.1 Determined By Committee. The Participants and the Benefits they
receive under the Plan shall be determined solely by the Committee. In making
its determinations, the Committee shall consider past, present and expected
future contributions of Participants and potential Participants to the Employer,
including, without limitation, the performance of, or the refraining from the
performance of, services.

                                    ARTICLE V

                                 ADMINISTRATION

            5.1 Committee. The Plan shall be administered by the Committee. The
Committee shall consist of three or more members of the Board each of whom is a
"Non-Employee Director" as defined in Rule 16b-3 and who is an "outside
director" as defined in Code Section 162(m)(4)(C)(i). The members of the
Committee shall be appointed by and shall serve at the pleasure of the Board,
which may from time to time appoint members in substitution for members
previously appointed and fill vacancies, however caused, in the Committee. The
Committee may select one of its members as its Chairman and shall hold its
meetings at such times and places as it may determine. A majority of its members
shall constitute a quorum. All determinations of the Committee shall be made by
a majority of its members. Any decision or determination reduced to writing and
signed by a majority of the members shall be fully as effective as if it had
been made by a majority vote at a meeting duly called and held.

            5.2 Authority. Subject to the terms of the Plan, the Committee shall
have discretionary authority to:

            (a) determine the individuals to whom Benefits are granted, the type
and amounts of Benefits to be granted and the time of all such grants;

            (b) determine the terms, conditions and provisions of, and
restrictions relating to, each Benefit granted;

            (c) interpret and construe the Plan and all Agreements;

            (d) prescribe, amend and rescind rules and regulations relating to
the Plan;

            (e) determine the content and form of all Agreements;

            (f) determine all questions relating to Benefits under the Plan;

            (g) maintain accounts, records and ledgers relating to Benefits;

            (h) maintain records concerning its decisions and proceedings;

            (i) employ agents, attorneys, accountants or other persons for such
purposes as the Committee considers necessary or desirable;

                                       4
<PAGE>
            (j) take, at anytime, any action permitted by Section 9.1
irrespective of whether any Change of Control has occurred or is imminent; and

            (k) do and perform all acts which it may deem necessary or
appropriate for the administration of the Plan and carry out the purposes of the
Plan.

            5.3 Delegation. Except as required by Rule 16b-3 with respect to
grants of Options, Stock Appreciation Awards, Performance Shares, Other Stock
Based Awards, or other Benefits to individuals who are subject to Section 16 of
the Exchange Act or as otherwise required for compliance with Rule 16b-3, Code
Section 162(m), or other applicable law, the Committee may delegate all or any
part of its authority under the Plan to any Employee, Employees or committee.

            5.4 Adjudication of Claims. The Committee shall have full and
complete discretionary authority to make all determinations as to the right to
Benefits under the Plan. In the event that a Participant believes he has not
received the Benefits to which he is entitled under the Plan, a claim shall be
made in writing to the Committee. The claim shall be reviewed by the Committee.
If the claim is approved or denied, in full or in part, the Committee shall
provide a written notice of approval or denial within 90 days with, in the case
of a denial, the specific reasons for the denial and specific reference to the
provisions of the Plan and/or Agreement upon which the denial is based. A claim
shall be deemed denied if the Committee does not take any action within the
aforesaid 90 day period. If a claim is denied or deemed denied and a review is
desired, the Participant shall notify the Committee in writing within 60 days of
the receipt of notice of denial or the date on which the claim is deemed to be
denied, as the case may be. In requesting a review, the Participant may review
the Plan or any document relating to it and submit any written issues and
comments he may deem appropriate. The Committee shall then review the claim and
provide a written decision within 60 days. This decision, if adverse to the
Participant, shall state the specific reasons for the decision and shall include
reference to specific provisions of the Plan and/or Agreement on which the
decision is based. The Committee's decision on review shall be final and
binding.

                                   ARTICLE VI

                                    AMENDMENT

            6.1 Power of Board. Except as hereinafter provided, the Board shall
have the sole right and power to amend the Plan at any time and from time to
time.

            6.2 Limitation. The Board may not amend the Plan, without approval
of the shareholders of the Company:

            (a) in a manner which would cause Options which are intended to
qualify as ISOs to fail to qualify;

            (b) in a manner which would cause the Plan to fail to meet the
requirements of Rule 16b-3 or Code Section 162(m); or

            (c) in a manner which would violate applicable law.

                                       5
<PAGE>
                                   ARTICLE VII

                              TERM AND TERMINATION

            7.1 Term. The Plan shall commence as of the Effective Date and,
subject to the terms of the Plan, including those requiring approval by the
shareholders of the Company and those limiting the period over which ISOs or any
other Benefits may be granted, shall continue in full force and effect until
terminated.

            7.2 Termination. The Plan may be terminated at any time by the
Board.

                                  ARTICLE VIII

                     MODIFICATION OR TERMINATION OF BENEFITS

            8.1 General. Subject to the provisions of Section 8.2, the amendment
or termination of the Plan shall not adversely affect a Participant's right to
any Benefit granted prior to such amendment or termination.

            8.2 Committee's Right. Any Benefit granted may be converted,
modified, forfeited or cancelled, in whole or in part, by the Committee if and
to the extent permitted in the Plan or applicable Agreement or with the consent
of the Participant to whom such Benefit was granted.

                                   ARTICLE IX

                                CHANGE OF CONTROL

            9.1 Right of Committee. In order to maintain a Participant's rights
in the event of a Change in Control, the Committee, in its sole discretion, may,
in any Agreement evidencing a Benefit, or at any time prior to, or
simultaneously with or after a Change in Control, provide such protection as it
may deem necessary. Without, in any way, limiting the generality of the
foregoing sentence or requiring any specific protection, the Committee may:

            (a) provide for the acceleration of any time periods relating to the
exercise or realization of such Benefit so that such Benefit may be exercised or
realized in full on or before a date fixed by the Committee;

            (b) provide for the purchase of such Benefit, upon the Participant's
request, for an amount of cash equal to the amount which could have been
attained upon the exercise or realization of such Benefit had such Benefit been
currently exercisable or payable;

            (c) make such adjustment to the Benefits then outstanding as the
Committee deems appropriate to reflect such transaction or change; and/or

            (d) cause the Benefits then outstanding to be assumed, or new
Benefits substituted therefor, by the surviving corporation in such change.

                                       6
<PAGE>
                                    ARTICLE X

                         AGREEMENTS AND CERTAIN BENEFITS

            10.1 Grant Evidenced by Agreement. The grant of any Benefit under
the Plan may be evidenced by an Agreement which shall describe the specific
Benefit granted and the terms and conditions of the Benefit. The granting of any
Benefit shall be subject to, and conditioned upon, the recipient's execution of
any Agreement required by the Committee. Except as otherwise provided in an
Agreement, all capitalized terms used in the Agreement shall have the same
meaning as in the Plan, and the Agreement shall be subject to all of the terms
of the Plan.

            10.2 Provisions of Agreement. Each Agreement shall contain such
provisions that the Committee shall determine to be necessary, desirable and
appropriate for the Benefit granted which may include, but not be limited to,
the following with respect to any Benefit: description of the type of Benefit;
the Benefit's duration; its transferability; if an Option, the exercise price,
the exercise period and the person or persons who may exercise the Option; the
effect upon such Benefit of the Participant's death or termination of
employment; the Benefit's conditions; when, if, and how any Benefit may be
forfeited, converted into another Benefit, modified, exchanged for another
Benefit, or replaced; and the restrictions on any Shares purchased or granted
under the Plan.

            10.3 Certain Benefits. Except as otherwise expressly provided in an
Agreement, any Benefit granted to an individual who is subject to Section 16 of
the Exchange Act shall be not transferable other than by will or the laws of
descent and distribution and shall be exercisable during his lifetime only by
him, his guardian or his legal representative.

                                   ARTICLE XI

                          REPLACEMENT AND TANDEM AWARDS

            11.1 Replacement. The Committee may permit a Participant to elect to
surrender a Benefit in exchange for a new Benefit.

            11.2 Tandem Awards. Awards may be granted by the Committee in
tandem. However, no Benefit may be granted in tandem with an ISO except SARs.

                                   ARTICLE XII

                  PAYMENT, DIVIDENDS, DEFERRAL AND WITHHOLDING

            12.1 Payment. Upon the exercise of an Option or in the case of any
other Benefit that requires a payment to the Company, the amount due the Company
is to be paid:

            (a) in cash;

            (b) by the tender to the Company of Shares owned by the optionee and
registered in his name having a Fair Market Value equal to the amount due to the
Company;

                                       7
<PAGE>
            (c) in other property, rights and credits, including the
Participant's promissory note if permitted under applicable law; or

            (d) by any combination of the payment methods specified in (a), (b)
and (c) above.

            Notwithstanding, the foregoing, any method of payment other than (a)
may be used only with the consent of the Committee or if and to the extent so
provided in an Agreement. The proceeds of the sale of Common Stock purchased
pursuant to an Option and any payment to the Company for other Benefits shall be
added to the general funds of the Company or to the Shares held in treasury, as
the case may be, and used for the corporate purposes of the Company as the Board
shall determine.

            12.2 Dividend Equivalents. Grants of Benefits in Shares or Share
equivalents may include dividend equivalent payments or dividend credit rights.

            12.3 Deferral. The right to receive any Benefit under the Plan may,
at the request of the Participant, be deferred for such period and upon such
terms as the Committee shall determine, which may include crediting of interest
on deferrals of cash and crediting of dividends on deferrals denominated in
Shares.

            12.4 Withholding. The Company, at the time any distribution is made
under the Plan, whether in cash or in Shares, may withhold from such
distribution any amount necessary to satisfy federal, state and local income tax
withholding requirements with respect to such distribution. Such withholding may
be in cash or in Shares.

                                  ARTICLE XIII

                                     OPTIONS

            13.1 Types of Options. It is intended that both ISOs and NQSOs may
be granted by the Committee under the Plan.

            13.2 Shares for ISOs. The number of Shares for which ISOs may be
granted on or after the Effective Date shall not exceed 150,000 Shares.

            13.3 Grant of ISOs and Option Price. Each ISO must be granted to an
Employee and granted within ten years from the Effective Date. The purchase
price for Shares under any ISO shall be no less than the Fair Market Value of
the Shares at the time the Option is granted.

            13.4 Other Requirements for ISOs. The terms of each Option which is
intended to qualify as an ISO shall meet all requirements of Section 422 of the
Code.

            13.5 NQSOs. The terms of each NQSO shall provide that such Option
will not be treated as an ISO. The purchase price for Shares under any NQSO
shall be equal to or greater than the Fair Market Value of the Shares at the
time the Option is granted.

            13.6 Determination by Committee. Except as otherwise provided in
Section 13.2 through Section 13.5, the terms of all Options shall be determined
by the Committee.

                                       8
<PAGE>
            13.7 Limitation on Shares Covered by Options. The maximum number of
Shares with respect to which such Options may be granted to any Participant in
any 1 year period shall not exceed 200,000 shares. For purposes of the preceding
sentence, the Shares covered by an Option that is cancelled shall count against
the maximum number of Shares, and, if the exercise price under an Option is
reduced, the transaction shall be treated as a cancellation of the Option and a
grant of a new Option.

                                   ARTICLE XIV

                                      SARS

            14.1 Grant and Payment. The Committee may grant SARs. Upon electing
to receive payment of a SAR, a Participant shall receive payment in cash, in
Common Stock, or in any combination of cash and Common Stock, as the Committee
shall determine.

            14.2 Grant of Tandem Award. The Committee may grant SARs in tandem
with an Option, in which case: the exercise of the Option shall cause a
correlative reduction in SARs standing to a Participant's credit which were
granted in tandem with the Option; and the payment of SARs shall cause a
correlative reduction of the Shares under such Option.

            14.3 ISO Tandem Award. When SARs are granted in tandem with an ISO,
the SARs shall have such terms and conditions as shall be required for the ISO
to qualify as an ISO.

            14.4 Payment of Award. SARs shall be paid, to the extent payment is
elected by the Participant (and is otherwise due and payable), as soon as
practicable after the date on which such election is made.

            14.5 Limitation on SARs. The maximum number of SARs which may be
granted to any Participant in any 1 year period shall not exceed 15,000 SARs.
For purposes of the preceding sentence, any SARs that are cancelled shall count
against the maximum number of SARs, and, if the Fair Market Value of a Share on
which the appreciation under a SAR will be calculated is reduced, the
transaction shall be treated as a cancellation of the SAR and a grant of a new
SAR.

                                   ARTICLE XV

                                RESTRICTED STOCK

            15.1 Description. The Committee may grant Benefits in Shares
available under ARTICLE III of the Plan as Restricted Stock. Shares of
Restricted Stock shall be issued and delivered at the time of the grant but
shall be subject to forfeiture until provided otherwise in the applicable
Agreement or the Plan. Each certificate representing Shares of Restricted Stock
shall bear a legend referring to the Plan and the risk of forfeiture of the
Shares and stating that such Shares are nontransferable until all restrictions
have been satisfied and the legend has been removed. The grantee shall be
entitled to full voting and dividend rights with respect to all shares of
Restricted Stock from the date of grant.

            15.2 Cost of Restricted Stock. Grants of Shares of Restricted Stock
shall be made at a per Share cost to the Participant equal to par value.

                                       9
<PAGE>
            15.3 Non-Transferability. Shares of Restricted Stock shall not be
transferable until after the removal of the legend with respect to such Shares.
ARTICLE XVI

                               PERFORMANCE SHARES

            16.1 Description. Performance Shares are the right of an individual
to whom a grant of such Shares is made to receive Shares or cash equal to the
Fair Market Value of such Shares at a future date in accordance with the terms
of such grant. Generally, such right shall be based upon the attainment of
targeted profit and/or performance objectives.

            16.2 Grant. The Committee may grant an award of Performance Shares.
The number of Performance Shares and the terms and conditions of the grant shall
be set forth in the applicable Agreement.

                                  ARTICLE XVII

                                   CASH AWARDS

            17.1 Grant. The Committee may grant Cash Awards at such times and
(subject to Section 17.2) in such amounts as it deems appropriate.

            17.2 Limitation on Amount. The Amount of any Cash Award in any
Fiscal Year to any Participant who is subject to Section 16 of the Exchange Act
shall not exceed the greater of $100,000 or 50% of his cash compensation
(excluding any Cash Award under this ARTICLE XVII) for such Fiscal Year.

            17.3 Restrictions. Cash Awards may be subject or not subject to
conditions (such as an investment requirement), restricted or nonrestricted,
vested or subject to forfeiture and may be payable currently or in the future or
both.

                                  ARTICLE XVIII

                   OTHER STOCK BASED AWARDS AND OTHER BENEFITS

            18.1 Other Stock Based Awards. The Committee shall have the right to
grant Other Stock Based Awards which may include, without limitation, the grant
of Shares based on certain conditions, the payment of cash based on the
performance of the Common Stock, and the grant of securities convertible into
Shares.

            18.2 Other Benefits. The Committee shall have the right to provide
types of Benefits under the Plan in addition to those specifically listed, if
the Committee believes that such Benefits would further the purposes for which
the Plan was established.

                                   ARTICLE XIX

                            MISCELLANEOUS PROVISIONS

            19.1 Underscored References. The underscored references contained in
the Plan are included only for convenience, and they shall not be construed as a
part of the Plan or in any respect affecting or modifying its provisions.

                                       10
<PAGE>
            19.2 Number and Gender. The masculine and neuter, wherever used in
the Plan, shall refer to either the masculine, neuter or feminine; and, unless
the context otherwise requires, the singular shall include the plural and the
plural the singular.

            19.3 Governing Law. This Plan shall be construed and administered in
accordance with the laws of the State of Missouri.

            19.4 Purchase for Investment. The Committee may require each person
purchasing Shares pursuant to an Option or other award under the Plan to
represent to and agree with the Company in writing that such person is acquiring
the Shares for investment and without a view to distribution or resale. The
certificates for such Shares may include any legend which the Committee deems
appropriate to reflect any restrictions on transfer. All certificates for Shares
delivered under the Plan shall be subject to such stock-transfer orders and
other restrictions as the Committee may deem advisable under all applicable
laws, rules and regulations, and the Committee may cause a legend or legends to
be put on any such certificates to make appropriate references to such
restrictions.

            19.5 No Employment Contract. The adoption of the Plan shall not
confer upon any Employee any right to continued employment nor shall it
interfere in any way with the right of the Employer to terminate the employment
of any of its Employees at any time.

            19.6 No Effect on Other Benefits. The receipt of Benefits under the
Plan shall have no effect on any benefits to which a Participant may be entitled
from the Employer, under another plan or otherwise, or preclude a Participant
from receiving any such benefits.

WLH:mef/rgafspJul98/rga

                                       11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00062-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00062-of-00352.parquet"}]]